Allergan Officially Adds Coolsculpting to Portfolio

April 27, 2017
ReachMD Healthcare Image

It’s a done deal.

Allergan now owns ZELTIQ® Aesthetics.

Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash.

ZELTIQ® stockholders approved the transaction during its stockholder meeting held on April 27, 2017. With the acquisition, Allergan adds ZELTIQ's flagship CoolSculpting® System to their portfolio.

 

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free